.After declaring a period 3 launch based upon favorable midstage results, iTeos and also GSK are las...
.The FDA must be more open and also collaborative to release a rise in approvals of rare illness med...
.It's an uncommonly active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Rehabs all ...
.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 trial, however the biotech still st...
.Neurocrine Biosciences' mental illness plan pivot has actually fallen short. The biotech was actual...
.Sanofi has brought in an overdue entry to the radioligand gathering, spending 100 thousand european...
.After F2G's initial attempt to obtain a brand-new class of antifungal to market was derailed by the...
.Moderna has sworn to cut R&D investing by $1.1 billion by 2027. The decision to shrink the spend...
.Only 4 months after Sanofi bet $80 million in beforehand cash on Pivot Therapeutics' losmapimod, th...
.Cancer cells provider Oncternal Rehabs is folding all its professional tests and also giving up sta...